ZLDPF OTC
Zealand Pharma A/S
1W: -4.7%
1M: -15.4%
3M: -12.3%
YTD: -44.6%
1Y: -47.9%
3Y: -4.8%
5Y: +43.6%
$40.00
+1.90 (+4.99%)
Weekly Expected Move ±8.2%
$33
$37
$40
$43
$47
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$6.5B
+800.2% ▲
Capital Expenditures
$33M
-153.2% ▼
5Y CAGR: +5.9%
Free Cash Flow
$6.5B
+786.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$406M
-15.5% ▼
Net Change in Cash
$4.1B
+13269.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1.0B | -$1.2B | -$704M | -$1.1B | $6.4B |
| Depreciation & Amort. | $40M | $118M | $25M | $26M | $27M |
| Stock-Based Comp. | $54M | $52M | $61M | $87M | $0 |
| Change in Working Capital | -$166M | $10M | $52M | $122M | $88M |
| Other Non-Cash Items | -$120M | $79M | $139M | -$87M | -$38M |
| Operating Cash Flow | -$1.2B | -$942M | -$426M | -$931M | $6.5B |
| — Investing Activities — | |||||
| Capital Expenditures | -$22M | -$12M | -$11M | -$10M | -$69M |
| Acquisitions (Net) | $0 | $106M | $0 | $0 | $0 |
| Investment Purchases | $0 | -$700M | -$2.2B | -$11.5B | -$14.3B |
| Investment Sales | $0 | $887M | $1.1B | $4.1B | $12.1B |
| Other Investing | $4M | $293M | -$13M | -$3M | $24M |
| Investing Cash Flow | -$18M | $281M | -$1.1B | -$7.3B | -$2.2B |
| — Financing Activities — | |||||
| Net Debt Issuance | $648M | -$436M | -$526M | $370M | $0 |
| Stock Repurchased | -$29M | $0 | -$42M | -$352M | -$406M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$62M | -$61M | -$90M | -$253M | -$20M |
| Financing Cash Flow | $1.3B | $587M | $907M | $8.3B | -$377M |
| Net Change in Cash | $169M | -$60M | -$620M | $31M | $4.1B |
| Cash End of Period | $1.1B | $1.1B | $449M | $480M | $4.6B |
| Free Cash Flow | -$1.2B | -$954M | -$449M | -$944M | $6.5B |